Akanda PE Ratio 2021-2023 | AKAN
Current and historical p/e ratio for Akanda (AKAN) from 2021 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Akanda PE ratio as of May 23, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Akanda PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-23 | 2.39 | inf | |
| 2023-12-31 | 0.44 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.001B | $0.002B |
| Akanda Corp. provides medical cannabis and wellness platform. The company's initial portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. Akanda Corp. is based in LONDON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.348B | 23.88 |
| Stryker (SYK) | United States | $127.778B | 30.60 |
| Medtronic (MDT) | Ireland | $113.874B | 16.12 |
| Boston Scientific (BSX) | United States | $110.575B | 35.22 |
| EssilorLuxottica (ESLOY) | France | $101.753B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.598B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.812B | 28.33 |
| ResMed (RMD) | United States | $32.065B | 30.11 |
| Koninklijke Philips (PHG) | Netherlands | $25.241B | 19.55 |
| Terumo (TRUMY) | Japan | $24.969B | 35.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.550B | 15.68 |
| Baxter (BAX) | United States | $17.504B | 12.45 |
| Insulet (PODD) | United States | $12.683B | 56.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.205B | 0.00 |
| Demant (WILYY) | Denmark | $10.615B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.325B | 27.22 |
| BellRing Brands (BRBR) | United States | $7.616B | 35.82 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.05 |
| Haemonetics (HAE) | United States | $4.580B | 22.64 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $3.998B | 12.12 |
| Prestige Consumer Healthcare (PBH) | United States | $3.231B | 15.38 |
| Envista Holdings (NVST) | United States | $3.202B | 13.21 |
| Neogen (NEOG) | United States | $2.931B | 28.19 |
| QuidelOrtho (QDEL) | United States | $2.853B | 15.84 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.784B | 0.00 |
| TG Therapeutics (TGTX) | United States | $2.735B | 76.96 |
| Green Thumb Industries (GTBIF) | United States | $2.585B | 51.21 |
| ICU Medical (ICUI) | United States | $2.573B | 22.71 |
| Agios Pharmaceuticals (AGIO) | United States | $1.898B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.796B | 52.65 |
| Warby Parker (WRBY) | United States | $1.671B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.628B | 0.00 |
| InMode (INMD) | Israel | $1.604B | 8.53 |
| Owens & Minor (OMI) | United States | $1.359B | 11.84 |
| AdaptHealth (AHCO) | United States | $1.295B | 9.62 |
| National Vision Holdings (EYE) | United States | $1.207B | 38.40 |
| AtriCure (ATRC) | United States | $1.082B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.007B | 0.00 |
| Evolus (EOLS) | United States | $0.810B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.792B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.746B | 15.87 |
| Cresco Labs (CRLBF) | United States | $0.696B | 0.00 |
| Quanterix (QTRX) | United States | $0.648B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.611B | 14.38 |
| Valneva SE (VALN) | France | $0.608B | 0.00 |
| PetIQ (PETQ) | United States | $0.591B | 19.11 |
| Surmodics (SRDX) | United States | $0.503B | 31.49 |
| ZimVie (ZIMV) | United States | $0.475B | 40.51 |
| TerrAscend (TSNDF) | Canada | $0.475B | 0.00 |
| Jin Medical (ZJYL) | China | $0.443B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.374B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.373B | 12.02 |
| Biote (BTMD) | United States | $0.362B | 8.33 |
| Cerus (CERS) | United States | $0.357B | 0.00 |
| Zynex (ZYXI) | United States | $0.333B | 45.52 |
| MacroGenics (MGNX) | United States | $0.294B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 27.04 |
| Sanara MedTech (SMTI) | United States | $0.261B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.96 |
| Veru (VERU) | United States | $0.201B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.199B | 0.00 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.173B | 83.00 |
| InterCure (INCR) | Israel | $0.141B | 23.85 |
| Quipt Home Medical (QIPT) | United States | $0.137B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 18.30 |
| Cellectar Biosciences (CLRB) | United States | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 8.40 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| MariMed (MRMD) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.086B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.078B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Safety Shot (SHOT) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.049B | 3.23 |
| Bright Green (BGXX) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.15 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |